Ovarian Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of Folatescan (Technetium TC 99M EC20) in patients with suspected ovarian carcinom…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 1, Phase 2]
Phase 1/2 trial evaluating CDX-1401, Poly ICLC, and INCB024360 in remission for ovarian, fallopian tube, or primary peritoneal cancer comple…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy [EARLY_Phase 1]
Early-phase pilot trial of denosumab in BRCA1/2 mutation carriers scheduled for risk-reducing salpingo-oophorectomy was terminated.
-
CLINICAL_TRIALS withdrawal · 2022-04-15Clinical Trial Update: Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers [Phase 2, Phase 3]
Clinical trial evaluating secondary cytoreductive surgery in platinum-resistant recurrent ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Niraparib Plus Anlotinib for Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating niraparib plus anlotinib for recurrent ovarian cancer; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating albumin-bound paclitaxel in combination with bevacizumab for platinum-resistant recurrent ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial evaluating symptom benefit rate of trabectedin plus pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer was term…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating pemetrexed and carboplatin for recurrent ovarian, primary peritoneal, or fallopian tube cancer has complet…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer [Phase 2]
Phase II study of Intraperitoneal NanoPac in ovarian cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies [Phase 2]
Phase 2 clinical trial of selinexor (KPT-330) in female patients with advanced gynecologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
A Phase 2 trial evaluating chemotherapy in ovarian, fallopian tube, and peritoneal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab, bevacizumab, and cyclophosphamide in recurrent ovarian, fallopian tube, or primary peritone…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of everolimus and letrozole in patients with recurrent hormone receptor-positive ovarian…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries [Phase 2]
Phase 2 trial evaluating zoledronate versus observation for maintaining bone mineral density in patients undergoing surgery to remove both o…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib versus paclitaxel for persistent or recurrent epithelial ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for cabozantinib-s-malate in recurrent or progressive ovarian, fallopian tube, or primary peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery [NA]
Clinical trial completed evaluating mindfulness movement and breathing to improve outcomes in participants undergoing gynecologic surgery; r…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer [Phase 2]
Phase 2 trial update evaluating weekly carboplatin and docetaxel for recurrent ovarian or primary peritoneal cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without viral therapy in recurrent or persistent ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating elesclomol sodium with paclitaxel in patients with recurrent or persistent ovarian epithelial cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating sorafenib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in recurrent or persistent ovarian, fallopian tube, endometrial, or peritoneal cancers; study terminated …
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for MLN8237 in ovarian, fallopian tube, or peritoneal carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating levonorgestrel to prevent ovarian cancer in high-risk patients has completed with results posted.